Anuja Majmundar, PhD, MBA

Principal Scientist, Tobacco Control Research

How I can make a difference

"The tobacco marketplace is dynamic and evolving. I develop scalable surveillance systems that leverage real-time digital data and computational social science approaches. With these systems,my research provides timely intelligence for evidence-based tobacco-related health policies, interventions, and advocacy efforts."

At ACS since 2021

As Principal Scientist, Anuja Majmundar, PhD, MBA, leads digital tobacco surveillance efforts in the Tobacco Control team, Surveillance & Health Equity Science department, at the American Cancer Society (ACS). 

Majmundar’s research is driven by three aims, to:

  1. Generate timely and evidence-based tobacco policies and interventions by harnessing real-time data.
  2. Maximize the impact of tobacco control efforts by developing scalable digital surveillance systems. 
  3. Improve our responsiveness to the youth vaping epidemic in the U.S by conceptualizing novel digital data-analytic methods.

Research focus and accomplishments

Majmundar’s research focuses on new and emerging tobacco products, such as electronic cigarettes. Her work highlights two key areas: regulatory gaps pertaining to online vape marketing practices that target vulnerable populations and youth-appealing features of vaping products.

Majmundar's research studies:

  • Demonstrate the utility of social-media data in real-time syndromic surveillance.
  • Characterize online health misinformation.
  • Outline strategies for effective tobacco education campaigns via social media.
  • Identify factors that drive public support for e-cigarette policies.
  • Explore just-in-time smoking cessation interventions, including factors required for effective cellphone ‘nudges.’ 
  • Model longitudinal social-media data to infer public attitudes towards the use of vaping products. 

Her trans-disciplinary research spans public health, medicine, informatics, computer science, behavioral science, marketing, and communication and has informed local- and federal-level tobacco policies. 

As an expert in digital tobacco surveillance, Majmundar is an invited participant for panels at prominent public health conferences. She was most recently on a panel at the Society of Behavioral Medicine and the American Public Health Association. 

Majmundar's research and training has been supported by the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). 


Majmundar is an Editorial Advisory Board member at the Behavioral Medicine journal and Tobacco Control Section Lead as part of the Journal of Medical Internet Research (JMIR) Infodemiology Editorial Board during 2021-2024.

She is also co-guest editing a special issue on the “The Impact of COVID-19 on Tobacco and Nicotine Use” at th the Nicotine & Tobacco Research journal.

She has authored more than 30 peer-reviewed publications. For a full list of Dr. Majmundar's publications, visit her Google Scholar page.



  • PhD: Health Behavior Research, Keck School of Medicine, University of Southern California, 2016-2020
  • MA: Communication Studies, San Diego State University, 2014-2016
  • MBA: Communication Management, 2007-2009